ARMGO Pharma, Inc. vs Myrobalan Therapeutics

ARMGO Pharma, Inc.

First-in-Class Disease-Modifying Therapeutics in Cardiac and Skeletal Muscle Diseases

12 employees · est. 2006 · United States

Myrobalan Therapeutics

Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS disorders

27 employees · est. 2021 · Medford, United States

ARMGO Pharma, Inc. is the older company (2006 vs 2021).

Side-by-Side Comparison

Metric	ARMGO Pharma, Inc.	Myrobalan Therapeutics
Founded
Founded	2006 older	2021
Headquarters
Headquarters	United States	Medford, United States
Employees
Employees	12	27
Industry
Industry	Biotechnology, Health and Wellness, Platforms	Biotechnology, Health Care, Health and Wellness
Funding Stage
Funding Stage	Series B	Grant
Total Funding
Total Funding	$36.00M	$24.40M
Funding Rounds
Funding Rounds	2	2
Taxonomy
Taxonomy	BiopharmaceuticalTherapeuticsSmall-moleculeCardiac DisordersMuscular DisordersNeurological Disorders +9	BiopharmaceuticalsCNS DisordersNeurodegenerative DiseasesDemyelinating DisordersNeuropsychiatric DisordersSmall Molecule Drugs +5
Website
Website	armgo.com	myrotx.com

About ARMGO Pharma, Inc.

ARMGO Pharma, Inc. is a biopharmaceutical company that has been developing targeted small-molecule therapeutics to combat severe cardiac, skeletal muscular, and neurological disorders since 2004. The company's flagship products, rycals, act as calcium release channel stabilizers targeting the ryanod...

View Full Profile

About Myrobalan Therapeutics

Myrobalan Therapeutics is a biotechnology startup founded in 2021 with the mission to develop first-in-class and best-in-class small molecule drugs for CNS disorders. The company focuses on addressing the unmet need and societal burdens posed by neurodegenerative, demyelinating, and neuropsychiatric...

View Full Profile

Also comparing in this category

We will tell you when either one moves

BounceWatch watches ARMGO Pharma, Inc. and Myrobalan Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when ARMGO Pharma, Inc. or Myrobalan Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Frequently Asked Questions

ARMGO Pharma, Inc. was founded in 2006, based in United States, with 12 employees. ARMGO Pharma, Inc. is a biopharmaceutical company that has been developing targeted small-molecule therapeutics to combat severe cardiac, skeletal muscular, and neurological disorders since 2004. The. Myrobalan Therapeutics was founded in 2021, based in Medford, United States, with 27 employees. Myrobalan Therapeutics is a biotechnology startup founded in 2021 with the mission to develop first-in-class and best-in-class small molecule drugs for CNS disorders. The company focuses on addressing.

ARMGO Pharma, Inc. has raised $36.00M and Myrobalan Therapeutics $24.40M. Latest stage: ARMGO Pharma, Inc. Series B, Myrobalan Therapeutics Grant.

Both work in Biotechnology and Health and Wellness and list therapeutics among their focus areas.

Compare ARMGO Pharma, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

All Companies All Signals

Compiled from the BounceWatch company index. We last looked at ARMGO Pharma, Inc. on 12 Sep 2024, and Myrobalan Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.